title: Treatment of the hypertensive patient with microvascular angina.
abstract: Syndrome X and microvascular angina are a heterogenous group of diseases. Several medications, including angiotensin-converting enzyme inhibitors, beta-blockers, and calcium-channel blockers, have been reported to be successful in the treatment of microvascular angina. Control of hypertension and regression of left ventricular hypertrophy are important in controlling symptoms associated with this intriguing problem. The role of nitric oxide and the effects of L-arginine in the pathogenesis and treatment of hypertension and microvascular angina need to be elucidated. Optimal treatment will depend on the appropriate classification and diagnosis of chest pain in patients with hypertension and normal coronary angiograms.
authors.affiliation: Department of Medicine, Tulane University Medical Center, New Orleans, Louisiana 70112, USA.
authors.forename: H
authors.initials: H
authors.lastname: Ventura
authors.forename: P
authors.initials: P
authors.lastname: Loyalka
authors.forename: F W
authors.initials: FW
authors.lastname: Smart
mesh_terms: D018674:Adrenergic Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D017023:Coronary Angiography; D003937:Diagnosis, Differential; D004452:Echocardiography; D015637:Gated Blood-Pool Imaging; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000188:drug therapy; D017566:Microvascular Angina / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D018674:Adrenergic Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers